January 2, 2025 - 20:05

The US stock market faced a challenging start to 2025, with major averages closing in negative territory for the fifth consecutive session. The Dow Jones Industrial Average experienced the steepest decline, dropping by 0.35%, which dampened Wall Street's hopes for a potential year-end rally. This continued downturn reflects ongoing investor concerns and market volatility as economic indicators remain uncertain.
As analysts review the performance of stocks from the previous year, attention is drawn to the resilience of some top performers in 2024. Despite the overall market slump, certain sectors and companies showed strength, providing a glimmer of hope for investors looking for opportunities amidst the losses. Market experts are closely monitoring these developments, offering insights into potential recovery strategies and the implications for the broader economy.
The ongoing trend raises questions about the factors influencing market performance as investors brace for the challenges that lie ahead in the new year.
March 27, 2026 - 07:31
Asian stocks mostly lower after Wall Street's worst day since start of Iran warFinancial markets across the Asia-Pacific region traded mostly lower on Friday, mirroring a severe downturn on Wall Street. The negative sentiment stemmed from growing investor doubts over a...
March 26, 2026 - 20:50
Better Home & Finance, Coinbase to offer mortgage backed by cryptocurrenciesA new financial partnership is bridging the worlds of digital assets and real estate. A novel mortgage program will allow prospective homebuyers to leverage their cryptocurrency investments to...
March 26, 2026 - 05:31
Is Gold a Smart Investment for Your 2026 Portfolio?As investors look ahead to 2026, many are questioning whether gold deserves a place in their financial strategy. Historically, the precious metal has been revered as a safe-haven asset, often...
March 25, 2026 - 01:51
BioStem Technologies Reports Fourth Quarter and Full Year 2025 Financial ResultsPOMPANO BEACH, Fla., March 24, 2026 – BioStem Technologies, Inc., a leader in regenerative medicine, has released its financial results for the fourth quarter and full year ended December 31,...